Literature DB >> 3292566

Recent rubella virus infection indicated by a low avidity of specific IgG.

K Hedman1, I Seppälä.   

Abstract

Rubella-specific IgG in acute-phase sera produces a characteristically altered zone termed "soft hemolysis" in the radial hemolysis test. Here, the soft hemolysis was shown to be a product of the purified IgG1 subclass isolated from acute-phase sera. In contrast, ordinary hemolysis was produced by IgG1 isolated from sera of previous rubella immunity, indicating that the subclass composition of IgG was not involved in the mechanism of soft hemolysis. A novel type of solid-phase immunoassay was developed for the avidity of virus-specific IgG. Acute-phase IgG (with soft hemolysis) was dissociated from rubella antigen in an enzyme immunoassay (EIA) test by hydrogen-bond disrupting agents under conditions where IgG of previous immunity (showing ordinary hemolysis) remained mostly bound. These data suggest that the mechanism of soft hemolysis is the avidity of rubella-specific IgG. The new quantitative avidity EIA was tested with sera taken from 169 subjects. Recent infection could be shown from sera taken weeks or months after primary rubella.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3292566     DOI: 10.1007/bf00917569

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  32 in total

1.  Application of the passive haemolysis test for the determination of rubella virus antibodies.

Authors:  K Skaug; I Orstavik; J C Ulstrup
Journal:  Acta Pathol Microbiol Scand B       Date:  1975-08

2.  VARIATIONS IN AFFINITIES OF ANTIBODIES DURING THE IMMUNE RESPONSE.

Authors:  H N EISEN; G W SISKIND
Journal:  Biochemistry       Date:  1964-07       Impact factor: 3.162

3.  Solid-phase radioimmunoassay of rubella virus immunoglobulin G and immunoglobulin M antibodies.

Authors:  K O Kalimo; O H Meurman; P E Halonen; B R Ziola; M K Viljanen; K Granfors; P Toivanen
Journal:  J Clin Microbiol       Date:  1976-08       Impact factor: 5.948

4.  Rubella and congenital rubella syndrome--United States, 1983-1984.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1984-09-21       Impact factor: 17.586

5.  Persistence of humoral and cell-mediated immunity to rubella virus in cloistered nuns and in schoolteachers.

Authors:  E Rossier; P H Phipps; J M Weber; O H Meurman
Journal:  J Infect Dis       Date:  1981-08       Impact factor: 5.226

6.  Rubella hemagglutinin prepared with alkaline extraction of virus grown in suspension culture of BHK-21 cells.

Authors:  P E Halonen; J M Ryan; J A Stewart
Journal:  Proc Soc Exp Biol Med       Date:  1967-05

7.  Rubella-virus hemagglutination-inhibition test.

Authors:  G L Stewart; P D Parkman; H E Hopps; R D Douglas; J P Hamilton; H M Meyer
Journal:  N Engl J Med       Date:  1967-03-09       Impact factor: 91.245

8.  Single-serum radial hemolysis to detect recent rubella virus infection.

Authors:  K Hedman; E M Salonen; J Keski-Oja; K Räihä
Journal:  J Infect Dis       Date:  1986-12       Impact factor: 5.226

9.  Rubella virus contains one capsid protein and three envelope glycoproteins, E1, E2a, and E2b.

Authors:  C Oker-Blom; N Kalkkinen; L Kääriäinen; R F Pettersson
Journal:  J Virol       Date:  1983-06       Impact factor: 5.103

10.  Subclass distribution of rubella virus-specific immunoglobulin G.

Authors:  G A Linde
Journal:  J Clin Microbiol       Date:  1985-01       Impact factor: 5.948

View more
  36 in total

1.  A new method with general diagnostic utility for the calculation of immunoglobulin G avidity.

Authors:  M H Korhonen; J Brunstein; H Haario; A Katnikov; R Rescaldani; K Hedman
Journal:  Clin Diagn Lab Immunol       Date:  1999-09

2.  Development and application of a GuHCl-modified ELISA to measure the avidity of anti-HPV L1 VLP antibodies in vaccinated individuals.

Authors:  Joseph G Dauner; Yuanji Pan; Allan Hildesheim; Troy J Kemp; Carolina Porras; Ligia A Pinto
Journal:  Mol Cell Probes       Date:  2012-01-18       Impact factor: 2.365

3.  Estimating duration of infection with avidity assays: potential limitations and recommendations for improvement.

Authors:  Johanna Varner; M Denise Dearing
Journal:  Ecohealth       Date:  2012-02-07       Impact factor: 3.184

Review 4.  Laboratory diagnosis of rubella: past, present and future.

Authors:  J E Cradock-Watson
Journal:  Epidemiol Infect       Date:  1991-08       Impact factor: 2.451

5.  Evolution of envelope-specific antibody responses in monkeys experimentally infected or immunized with simian immunodeficiency virus and its association with the development of protective immunity.

Authors:  K S Cole; J L Rowles; B A Jagerski; M Murphey-Corb; T Unangst; J E Clements; J Robinson; M S Wyand; R C Desrosiers; R C Montelaro
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

6.  Differentiation of primary from nonprimary genital herpes infections by a herpes simplex virus-specific immunoglobulin G avidity assay.

Authors:  M Hashido; S Inouye; T Kawana
Journal:  J Clin Microbiol       Date:  1997-07       Impact factor: 5.948

7.  Characterization of the HPV-specific memory B cell and systemic antibody responses in women receiving an unadjuvanted HPV16 L1 VLP vaccine.

Authors:  Joseph G Dauner; Yuanji Pan; Allan Hildesheim; Clayton Harro; Ligia A Pinto
Journal:  Vaccine       Date:  2010-06-17       Impact factor: 3.641

8.  Distinguishing acute from chronic and resolved hepatitis C virus (HCV) infections by measurement of anti-HCV immunoglobulin G avidity index.

Authors:  S Klimashevskaya; A Obriadina; T Ulanova; G Bochkova; A Burkov; A Araujo; Susan L Stramer; Leslie H Tobler; Michael P Busch; Howard A Fields
Journal:  J Clin Microbiol       Date:  2007-08-22       Impact factor: 5.948

9.  IgG avidity assay for estimation of the time after onset of hantavirus infection in colonized and wild bank voles.

Authors:  I Gavrilovskaya; N Apekina; N Okulova; V Demina; A Bernshtein; Y Myasnikov
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

10.  Puumala virus antibody and immunoglobulin G avidity assays based on a recombinant nucleocapsid antigen.

Authors:  H Kallio-Kokko; O Vapalahti; K Hedman; M Brummer-Korvenkontio; A Vaheri
Journal:  J Clin Microbiol       Date:  1993-03       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.